Behind the Mystery: Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Airing Weekdays at 7:30AM ET|PT on

Autoimmune Pulmonary Alveolar Proteinosis 

Autoimmune Pulmonary Alveolar Proteinosis, or aPAP, is a rare life-threatening lung disorder that occurs in about seven out of every one million people in the general population. It occurs when an oily substance that is normally present in the air sacs of the lungs builds up and causes a feeling of breathlessness that can worsen over time. 

The diagnosis of aPAP is challenging because the symptoms are nonspecific and similar to other more common pulmonary diseases. Ask your pulmonologist to confirm or rule out aPAP at no cost with the help of aPAP ClearPath™, a simple, accurate, and noninvasive autoantibody blood test. 

Behind The Mystery

Behind the Mystery: MCT8 Deficiency

MCT8 deficiency effects a child’s brain development, ability to gain weight, muscle strength, and the heart. It can also impact sleep and shorten life expectancy.

Behind The Mystery

Celebrating Rare Disease Day

Wendy Erler, Vice President of Patient Experience at Alexion, AstraZeneca, returns to The Balancing Act to discuss Alexion’s commitment to advancing early and accurate diagnoses